What is the clinical evidence from this study?

Study design: Review. Population: Diabetic cardiomyopathy.

What question did this study set out to answer?

To clarify the role of mitochondrial dysfunction in diabetic cardiomyopathy and explore therapeutic strategies.

March 16, 2026SHILAP Revista de lepidopterologíaOpen Access

Mitochondrial dysfunction in diabetic cardiomyopathy: a review of pathogenic mechanisms and therapeutic strategies

View Full Paper

Ask AI

Bookmark

Key result

Mitochondrial dysfunction is linked to ~25% lower myocardial ATP and cardiac impairment in diabetic mice.

Why the study?

Effective strategies specifically addressing diabetic cardiomyopathy remain limited, highlighting the urgent need to clarify its underlying pathogenesis.

Design

Review

Authors

YHYulian HuangZhejiang International Studies University QMQiao MaZhejiang International Studies University WWWei WangGeneral Cardiology

Discussion

Member takes

Implication

Should not yet change practice in diabetic cardiomyopathy; reinforces mitochondrial dysfunction as target for emerging therapies.

Key Points

To clarify the role of mitochondrial dysfunction in diabetic cardiomyopathy and explore therapeutic strategies.
Reviewed experimental and clinical findings on diabetic cardiomyopathy.
Examined metabolic derangements, oxidative stress, and programmed cell death mechanisms.
Highlighted mitochondria-targeted therapeutic strategies and lifestyle interventions.
Mitochondrial impairment significantly contributes to the progression of diabetic cardiomyopathy.
Excessive reactive oxygen species production and inflammation were noted as critical factors.
Emerging therapies, including small molecule antioxidants and gene-based therapies, show promise.

Structured PICO

Population

Patients and experimental models with diabetic cardiomyopathy (DCM)

Intervention

Mitochondria-targeted therapeutic strategies (including small molecule antioxidants, metabolic modulators, gene-based therapies, stem cell-derived exosomes, and lifestyle interventions)

Mitochondrial dysfunction is a central pathogenic mechanism in diabetic cardiomyopathy, making it a key target for emerging therapeutic strategies.

Limitations

Lack of specific clinical trial results
Heavy reliance on animal models for metabolic profiles

Cite This Study

Huang et al. (2026) conducted a review in Diabetic cardiomyopathy. Mitochondrial dysfunction is linked with a 25% decrease in myocardial ATP levels in high-fat diet-induced diabetic mice and corresponds with significant cardiac impairment.

synapsesocial.com/papers/69b79da78166e15b153aad59 https://doi.org/10.3389/fcvm.2026.1751243

Topics

Heart failure HFrEF treatment

View Full Paper

Ask AI

Bookmark

Mitochondrial dysfunction in diabetic cardiomyopathy: a review of pathogenic mechanisms and therapeutic strategies

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Topics

Mitochondrial dysfunction in diabetic cardiomyopathy: a review of pathogenic mechanisms and therapeutic strategies

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Also Consider

Topics

Also Consider